Synthetic Human Secretin in Children With Autism

• Status: Completed
• Trial end date: 2004-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to determine whether multiple doses of secretin are safe and effective in the treatment of children with autism.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Repligen Corporation
• Treatments: Secretin

Criteria

Autism